Skip to main content

Table 2 Summary of patients with categorisation, features, and pre- and post-testing diagnosis

From: Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era

Patient

Sex

Age

Category

Clinical presentation

Variants

Inheritance Studies

Revised diagnosis

1

M

11y

K–K

Spondyloepiphyseal dysplasia tarda

X- Linked

Hemizygous deletion of TRAPPC2 exon 6

Maternally inherited

Spondyloepiphyseal dysplasia tarda (X-Linked)†

2

F

10y

K–K

Spondyloepiphyseal dysplasia congenita

Heterozygous SOX9 c.508C > T, p.(Pro170Ser) variant detected

De-novo variant not present in parents

Surviving campomelic dysplasia (CD)†

3

F

5 m

K–K

Syndromal proportional extreme short stature, Chiari malformation type I, growth hormone deficiency, hydrocephalus. Suspected Laron syndrome

No pathogenic variants were detected

Not applicable

SD of unknown aetiology‡

4

F

0-1y

K–U

Mild fibrochondrogenesis type 2. Post radiological review, changed to severe otospondylomegaepiphyseal dysplasia

Heterozygous COL11A2

c.2542C > T p.(Gln848Ter) variant detected (mat)

Heterozygous COL11A2 c.3151-2delA variant detected (pat))

AR—one variant inherited from each parent—trans

Severe otospondylomegaepiphyseal dysplasia†

5

F

6y

K–U

Multiple epiphyseal dysplasia with non-specific myopathy, or metaphyseal dysplasia

Heterozygous MATN3 c.400G > A p.(Glu134Lys)

Variant not present in mother. Father not tested

Multiple epiphyseal dysplasia†

6

F

8y

K–U

Intrauterine growth restriction (IUGR), failure to thrive, developmental delay, microcephaly, dysmorphisms, short stature. Type of microcephalic osteodysplastic primordial dwarfism

Heterozygous PCNT c.5812C > T p.(Gln1928Ter) variant detected

Heterozygous PCNT c.9273 + 1G > C variant detected

AR—one variant inherited from each parent—trans

Microcephalic osteodysplastic primordial dwarfism type II†

7

M

3y

K–U

Metaphyseal chondromatosis with D2-hydroxyglutaric aciduria

Heterozygous IDH1 c.395G > A p.(Arg132His) variant detected

De novo—variant not present in parents

Metaphyseal chondromatosis with D2-hydroxyglutaric aciduria†

8

F

2y

K–U

Chondrodysplasia punctata. Query genetic or teratogen

No pathogenic variants were detected

Not applicable

Possible acquired aetiology§

9

F

11y

K–U

AR osteopetrosis (infantile onset)

Heterozygous

CLCN7 c.1468delC p.(Leu490fs) variant detected (pat)

Heterozygous

CLCN7 c.1853C > A p.(Ala618Asp) variant detected (mat), VUS

AR—one variant inherited from each parent—trans

AR osteopetrosis type 4 (infantile onset) †

10

M

12y

K–U

Acromesomelic dysplasia, Maroteaux type, or spondylarperipheral

No pathogenic variants were detected

Not applicable

SD of unknown aetiology‡

11

F

3y

K–U

Odontochondrodysplasia

No pathogenic variants were detected

Not applicable

Odontochondrodysplasia¶

12

M

1y

U–U

Disproportionate short stature, conductive hearing loss, percutaneous endoscopic gastrostomy fed, dysmorphisms

No pathogenic variants were detected

Not applicable

SD of unknown aetiology‡

13

F

2y

U–U

SD; congenital heart disease, hemimegaloencephaly, bilateral iris colobomata, hearing loss

Heterozygous EXT2 c.237G > A p.(Trp79Ter) variant detected (mat)

Heterozygous EXT2 c.1404 + 2 T > C variant detected (pat)

AR—one variant inherited from each parent—trans

Autosomal recessive exostosin glycosyltransferase 2 syndrome^

14

M

7y

U–U

Query EDS (classic type/collagenopathy), or Mandibular acrodysplasia type A

No pathogenic variants were detected

Not applicable

SD of unknown aetiology‡

15

F

6y

U–U

Unknown SD, rule out bone marrow transplant-related short stature

No pathogenic variants were detected

Not applicable

Bone marrow transplant-related short stature§

  1. Confirmed molecular diagnosis
  2. Unknown diagnosis
  3. §Possible acquired diagnosis
  4. Confirmed clinical diagnosis but nil molecular findings
  5. ^Possible molecular diagnosis
  6. K–K known condition–known condition; K–U known condition–unknown condition; U–U unknown condition–unknown condition; SD skeletal dysplasia; AR autosomal recessive; TRAPPC2 tracking protein particle complex, subunit 2; SOX6 sex determining region Y-box 6); COL11A2 collagen type XI alpha-2 chain; MATN3 matrilin-3; PCNT pericentrin; IDH1 isocitrate dehydrogenase 1; CLCN7 chloride voltage-gated channel 7; VUS variant of unknown significance; EXT2 exostosin glycosyltransferase 2; EDS Ehlers–Danlos syndrome